5.44
-0.13 (-2.33%)
| Penutupan Terdahulu | 5.57 |
| Jumlah Dagangan | 18,151 |
| Harga / Pendapatan (P/E Ke hadapan) | 2.66 |
| Harga / Jualan (P/S) | 1.54 |
| Harga / Buku (P/B) | 28.85 |
| Julat 52 Minggu |
| Margin Keuntungan | -146.93% |
| Margin Operasi (TTM) | -557.51% |
| EPS Cair (TTM) | -15.27 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -54.00% |
| Nisbah Semasa (MRQ) | 0.100 |
| Aliran Tunai Operasi (OCF TTM) | 15.96 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 42.76 M |
| Pulangan Atas Aset (ROA TTM) | -69.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - General (US) | Bercampur | Menaik |
| Drug Manufacturers - General (Global) | Bercampur | Menaik | |
| Stok | Scilex Holding Company | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.79 |
|
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - General |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 21.58% |
| % Dimiliki oleh Institusi | 18.55% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ashton Thomas Private Wealth, Llc | 30 Jun 2026 | 18,482 |
| Donald L. Hagan, Llc | 30 Sep 2025 | 11,873 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |